MetaVia (MTVA) Change in Cash (2015 - 2025)
MetaVia's (MTVA) quarterly Change in Cash came in at -$4.0 million in Q4 2025, up 29.25% YoY from -$3.1 million in Q4 2024, and down 20.74% on a QoQ basis from -$3.3 million in Q3 2025.
MetaVia (MTVA) Change in Cash (2015 - 2025) Analysis & Trends
MetaVia (MTVA) has 11 years of Change in Cash data on file, last reported at -$4.0 million in Q4 2025.
- Quarterly Change in Cash rose 29.25% year-over-year to -$4.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.7 million (up 10.58% YoY) and the FY2025 annual result came in at -$5.7 million, up 10.58% from the prior year.
- Change in Cash slipped to -$4.0 million in Q4 2025, from -$3.3 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $27.0 million in Q4 2022 to a low of -$6.4 million in Q1 2024.
- A 5-year average of $9850.0 and a median of -$2.8 million in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash tumbled 263.64% — and 2024, when it surged 662.16%.
- Tracing MTVA's Change in Cash over 5 years: stood at $9.4 million in 2021, then surged by 187.2% to $27.0 million in 2022, then plunged by 112.6% to -$3.4 million in 2023, then sank by 66.14% to -$5.7 million in 2024, then gained by 29.25% to -$4.0 million in 2025.
- The last three Change in Cash figures came in at -$4.0 million (Q4 2025), -$3.3 million (Q3 2025), and $6.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | MetaVia | 8.72 Mn | -3.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.00 Mn |
| Sep 30, 2025 | -3.31 Mn |
| Jun 30, 2025 | 6.40 Mn |
| Mar 31, 2025 | -4.83 Mn |
| Dec 31, 2024 | -5.65 Mn |
| Sep 30, 2024 | -6.27 Mn |
| Jun 30, 2024 | 11.95 Mn |
| Mar 31, 2024 | -6.45 Mn |
| Dec 31, 2023 | -3.40 Mn |
| Sep 30, 2023 | -2.85 Mn |
| Jun 30, 2023 | -2.13 Mn |
| Mar 31, 2023 | -2.55 Mn |
| Dec 31, 2022 | 27.01 Mn |
| Sep 30, 2022 | -2.49 Mn |
| Jun 30, 2022 | -2.71 Mn |
| Mar 31, 2022 | -4.83 Mn |
| Dec 31, 2021 | 9.40 Mn |
| Sep 30, 2021 | -2.53 Mn |
| Jun 30, 2021 | -3.52 Mn |
| Mar 31, 2021 | 2.95 Mn |